Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?

PLoS ONE - United States
doi 10.1371/journal.pone.0148939
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Is 'Evergreening' a Cause for Concern? A Legal Perspective

Journal of Commercial Biotechnology
BiotechnologyManagement of TechnologyEconomicsEconometricsInnovation
1969English

Digital Medicine Systems: An Evergreening Strategy or an Advance in Medication Management?

BMJ Evidence-Based Medicine
Medicine
2019English

Emergency Medicine: Open Access

English

Medicine Pricing, Optimal Patent Length and Social Welfare

Revista de Cercetare si Interventie Sociala
Social PsychologySociologyHealthPolitical Science
2019English

Natural Products for Medicine

Journal of Biomedicine and Biotechnology
2012English

Access to Medicine in an Era of Fractal Inequality

SSRN Electronic Journal
2010English

Access to Care for the Uninsured: Is Access to a Physician Enough?

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1999English

Surgical Medicine Open Access Journal

English

Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy